Table 2. Patients and clinical feature of NC vs. LSIL+.
Clinical features | Training set | Testing set | |||||
---|---|---|---|---|---|---|---|
NC (n=2,760) | LSIL+ (n=2,511) | P | NC (n=812) | LSIL+ (n=694) | P | ||
Age | *** | 0.0008 | |||||
Mean | 41.2 | 39.5 | 41.2 | 39.5 | |||
Range | 16–75 | 15–79 | 18–77 | 18–79 | |||
Cytology | *** | *** | |||||
Negative | 2,411 | 1,375 | 697 | 383 | |||
Positive | 349 | 1,136 | 115 | 311 | |||
HPV | *** | *** | |||||
Negative | 321 | 60 | 91 | 13 | |||
Positive | 2,439 | 2,451 | 721 | 681 | |||
Gravidity | 0.008 | 0.350 | |||||
≤2 | 1,304 | 1,094 | 373 | 302 | |||
>2 | 1,456 | 1,417 | 439 | 392 | |||
Parity | 0.799 | 0.818 | |||||
≤2 | 2,626 | 2,385 | 770 | 656 | |||
>2 | 134 | 126 | 42 | 38 | |||
Contraception | 0.539 | 0.228 | |||||
Condom | 906 | 845 | 259 | 242 | |||
No condom | 1,854 | 1,666 | 553 | 452 |
***, P<0.001. NC, normal cervix; LSIL, low-grade squamous intraepithelial lesions; HPV, human papillomavirus.